Ulcerative colitis Trials in Vancouver, Canada
Conditions / Ulcerative colitis / Vancouver, Canada
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
48 total trials for this combination
Showing top 10 of 48 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05535946 | ABTECT - Maintenance | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06937086 | Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study | RECRUITING | — |
| NCT02914522 | Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT06937086 | Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study | RECRUITING | — |
| NCT03518086 | An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) | COMPLETED | PHASE3 |
| NCT02435992 | Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT02118584 | Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies | TERMINATED | PHASE3 |
| NCT02914535 | Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06052059 | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04033445 | A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |